FDA Issues Warning Letters to Firms Marketing Products Containing 7-Hydroxymitragynine

On July 15, the U.S. Food and Drug Administration (FDA) announced seven recent warning letters sent to companies for illegally marketing products containing 7-hydroxymitragynine, also known as 7-OH. This action reflects the Agency’s growing concern around novel potent opioid products being marketed to U.S. consumers and sold online and in smoke shops, gas stations and ...